Total Payments
$1,106
2024 Payments
$146.84
Companies
20
Transactions
61
Medicare Patients
3,397
Medicare Billing
$505,490
Payment Breakdown by Category
Food & Beverage$944.04 (85.3%)
Education$146.84 (13.3%)
Other$15.38 (1.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $944.04 | 56 | 85.3% |
| Education | $146.84 | 4 | 13.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $15.38 | 1 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Supernus Pharmaceuticals, Inc. | $419.37 | 30 | $0 (2019) |
| SK Life Science, Inc. | $129.59 | 1 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $117.37 | 9 | $0 (2020) |
| Alexion Pharmaceuticals, Inc. | $100.00 | 1 | $0 (2024) |
| UCB, Inc. | $71.64 | 2 | $0 (2023) |
| CATALYST PHARMACEUTICALS, INC. | $33.44 | 2 | $0 (2024) |
| EMD Serono, Inc. | $25.83 | 2 | $0 (2017) |
| Egalet US Inc | $22.34 | 2 | $0 (2017) |
| Avanir Pharmaceuticals, Inc. | $20.98 | 1 | $0 (2017) |
| Janssen Biotech, Inc. | $20.08 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $146.84 | 4 | Alexion Pharmaceuticals, Inc. ($100.00) |
| 2023 | $219.98 | 4 | SK Life Science, Inc. ($129.59) |
| 2020 | $12.02 | 1 | Sunovion Pharmaceuticals Inc. ($12.02) |
| 2019 | $241.33 | 17 | Supernus Pharmaceuticals, Inc. ($204.62) |
| 2018 | $177.87 | 14 | Supernus Pharmaceuticals, Inc. ($177.87) |
| 2017 | $308.22 | 21 | Sunovion Pharmaceuticals Inc. ($68.64) |
All Payment Transactions
61 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/12/2024 | Neurelis, Inc. | VALTOCO (Drug) | Education | In-kind items and services | $13.40 | General |
| Category: EPILEPSY | ||||||
| 09/11/2024 | CATALYST PHARMACEUTICALS, INC. | FYCOMPA (Drug) | Education | Cash or cash equivalent | $16.72 | General |
| Category: NEUROLOGY | ||||||
| 07/25/2024 | CATALYST PHARMACEUTICALS, INC. | FYCOMPA (Drug) | Education | Cash or cash equivalent | $16.72 | General |
| Category: NEUROLOGY | ||||||
| 06/20/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Education | In-kind items and services | $100.00 | General |
| Category: Rare Disease | ||||||
| 12/03/2023 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $129.59 | General |
| 12/03/2023 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $58.47 | General |
| 08/09/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 05/05/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug), Ongentys | Food and Beverage | In-kind items and services | $12.81 | General |
| Category: Neuropsychiatry | ||||||
| 10/15/2020 | Sunovion Pharmaceuticals Inc. | KYNMOBI (Drug) | Food and Beverage | In-kind items and services | $12.02 | General |
| Category: CNS | ||||||
| 10/24/2019 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $9.89 | General |
| Category: CNS | ||||||
| 09/12/2019 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: CNS | ||||||
| 08/28/2019 | Supernus Pharmaceuticals, Inc. | OXTELLAR XR (Drug) | Food and Beverage | Cash or cash equivalent | $18.07 | General |
| Category: AED | ||||||
| 08/09/2019 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $18.31 | General |
| Category: AED | ||||||
| 07/22/2019 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $20.41 | General |
| Category: AED | ||||||
| 07/10/2019 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $12.37 | General |
| Category: AED | ||||||
| 06/14/2019 | Supernus Pharmaceuticals, Inc. | OXTELLAR XR (Drug) | Food and Beverage | Cash or cash equivalent | $15.63 | General |
| Category: AED | ||||||
| 06/08/2019 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $14.51 | General |
| Category: AED | ||||||
| 05/23/2019 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $25.82 | General |
| Category: AED | ||||||
| 05/23/2019 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $12.48 | General |
| Category: CNS | ||||||
| 05/08/2019 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $12.85 | General |
| Category: AED | ||||||
| 05/01/2019 | Supernus Pharmaceuticals, Inc. | OXTELLAR XR (Drug) | Food and Beverage | Cash or cash equivalent | $8.76 | General |
| Category: AED | ||||||
| 04/26/2019 | Supernus Pharmaceuticals, Inc. | OXTELLAR XR (Drug) | Food and Beverage | Cash or cash equivalent | $8.63 | General |
| Category: AED | ||||||
| 04/12/2019 | Supernus Pharmaceuticals, Inc. | OXTELLAR XR (Drug) | Food and Beverage | Cash or cash equivalent | $9.46 | General |
| Category: AED | ||||||
| 03/25/2019 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $13.83 | General |
| Category: AED | ||||||
| 03/06/2019 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $16.50 | General |
| Category: AED | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 918 | 1,047 | $356,462 | $114,709 |
| 2022 | 11 | 776 | 897 | $268,327 | $95,326 |
| 2021 | 12 | 796 | 11,536 | $501,533 | $149,008 |
| 2020 | 13 | 907 | 9,558 | $485,179 | $146,447 |
Total Patients
3,397
Total Services
23,038
Medicare Billing
$505,490
Procedure Codes
49
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 318 | 412 | $119,892 | $36,791 | 30.7% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 110 | 111 | $85,303 | $30,763 | 36.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 93 | 107 | $45,475 | $13,917 | 30.6% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2023 | 25 | 25 | $25,525 | $8,393 | 32.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 66 | 66 | $31,856 | $8,172 | 25.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 99 | 104 | $19,511 | $6,199 | 31.8% |
| 95830 | Insertion of electrodes for measurement of brain wave activity (eeg) | Office | 2023 | 14 | 14 | $6,776 | $5,437 | 80.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 25 | 25 | $15,354 | $3,329 | 21.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 79 | 86 | $1,892 | $722.40 | 38.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 33 | 37 | $1,628 | $374.52 | 23.0% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 15 | 15 | $1,170 | $221.70 | 18.9% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2023 | 30 | 34 | $1,156 | $209.79 | 18.1% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 11 | 11 | $924.00 | $181.06 | 19.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 222 | 293 | $69,777 | $24,826 | 35.6% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2022 | 63 | 63 | $49,959 | $18,017 | 36.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 100 | 118 | $38,398 | $15,791 | 41.1% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2022 | 44 | 45 | $45,945 | $15,371 | 33.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 85 | 85 | $40,873 | $13,548 | 33.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 104 | 116 | $18,647 | $6,655 | 35.7% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 34 | 39 | $1,428 | $407.40 | 28.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 68 | 78 | $1,272 | $231.21 | 18.2% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2022 | 32 | 36 | $1,020 | $230.29 | 22.6% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 12 | 12 | $828.00 | $199.56 | 24.1% |
| 85651 | Red blood cell sedimentation rate, to detect inflammation, non-automated | Office | 2022 | 12 | 12 | $180.00 | $50.67 | 28.2% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2021 | 11 | 10,602 | $212,000 | $51,391 | 24.2% |
About Dr. William Boles, MD
Dr. William Boles, MD is a Neurology healthcare provider based in Wilmington, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2010. The National Provider Identifier (NPI) number assigned to this provider is 1124349154.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Boles, MD has received a total of $1,106 in payments from pharmaceutical and medical device companies, with $146.84 received in 2024. These payments were reported across 61 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($944.04).
As a Medicare-enrolled provider, Boles has provided services to 3,397 Medicare beneficiaries, totaling 23,038 services with total Medicare billing of $505,490. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Wilmington, NC
- Active Since 06/14/2010
- Last Updated 05/27/2021
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1124349154
Products in Payments
- TROKENDI XR (Drug) $308.11
- OXTELLAR XR (Drug) $111.26
- APTIOM (Drug) $105.35
- ULTOMIRIS (Biological) $100.00
- FYCOMPA (Drug) $33.44
- Rebif (Biological) $25.83
- SPRIX (Drug) $22.34
- ONZETRA Xsail (Drug) $20.98
- STELARA (Biological) $20.08
- BOTOX (Biological) $19.11
- GILENYA (Drug) $18.57
- NUPLAZID (Drug) $16.01
- AMPYRA (Drug) $15.38
- VNS Therapy (Device) $13.58
- VALTOCO (Drug) $13.40
- Briviact (Drug) $13.17
- TYSABRI (Biological) $12.94
- INGREZZA (Drug) $12.81
- ACTHAR (Biological) $12.59
- KYNMOBI (Drug) $12.02
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Wilmington
Dr. Johny Ardeljan, Do, DO
Neurology — Payments: $10,389
Neurology $10,389
Alfred De Maria, Md, MD
Neurology — Payments: $7,542
Neurology $7,542
Panida Piboolnurak, Md, MD
Neurology — Payments: $5,344
Neurology $5,344
Karrie Grear, Md, MD
Neurology — Payments: $1,900
Neurology $1,900
Dr. Badal Jain, Md, MD
Neurology — Payments: $1,273
Neurology $1,273
Angelique Manasseh, Do, DO
Neurology — Payments: $679.94
Neurology $679.94